Hypertension affects 1 billion people worldwide and is a primary public health concern as the leading cause of premature mortality. A common polymorphism, the C677 T mutation in the gene, MTHFR, encoding the enzyme methylenetetrahydrofolate reductase (MTHFR) affects 12% of the UK and Irish population and is associated with an increased risk of hypertension (1) . The activity of MTHFR, which generates the predominant co-factor form of folate, 5 methyl-tetrahydrofolate, is dependent on flavin adenine dinucleotide (FAD), the co-enzyme form of riboflavin. Individuals homozygous for the MTHFR 677TT genotype have reduced MTHFR enzyme activity resulting in lower 5 methyl-THF concentrations (2) , however previous randomised controlled trials at our Centre have shown that blood pressure (BP) is highly responsive to riboflavin supplementation specifically in individuals with the TT genotype (3) . The mechanism explaining how this gene-nutrient interaction influences BP is unknown, but it may involve a nitric oxide (NO)-mediated effect on endothelial function (1) . The aim of this study was to investigate BP and endothelial function in adults stratified by MTHFR genotype.
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Differences between groups were assessed by ANOVA; values within a row with different superscript letters are significantly different, by Tuckey post-hoc test. Abbreviations: AIx, augmentation index; DBP, diastolic blood pressure; PWV, pulse wave velocity; SBP. Systolic BP.
